Ziad Ali, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boston Scientific (SIGNIFICANT), Amgen Inc.(SIGNIFICANT) SPEAKER'S BUREAU: AstraZeneca Pharmaceuticals(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Shockwave Medical(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Abiomed (SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Philips(SIGNIFICANT), Boston Scientific (SIGNIFICANT), Acist Medical (SIGNIFICANT), Cardiovascular Systems Inc(SIGNIFICANT), Medtronic(SIGNIFICANT)

View Full Disclosure